Make a referral

Assessment and treatment services

Search

Neuropsychology News: Neuropsychological Services Australia

US FDA grants orphan drug status for Mithridion's MCD-386CR to treat progressive supranuclear palsy PSP is a progressive brain disease in which neurons degenerate in regions of the brain vital for eye movements, balance, walking, speech, and cognition. Cognitive impairment typically involves slowed thinking, and difficulties with reasoning, planning, and shifting between tasks, caused by dysfunction of the brain's executive functions. This has been called “dysexecutive syndrome.” US FDA grants orphan drug status for Mithridion's MCD-386CR to treat progressive supranuclear palsy
PSP is a progressive brain disease in which neurons degenerate in regions of the brain vital for eye movements, balance, walking, speech, and cognition. cognitive impairment typically involves slowed thinking, and difficulties with reasoning, planning, and shifting between tasks, caused by dysfunction of the brain's executive functions. This has been called “dysexecutive syndrome.” - pharmabiz.com

Neuropsychology News Australia (RSS) RSS
54.226.36.60
Advanced Neuropsychological Treatment Services 'https://neurotreatment.com.au/img/advanced-neuropsychological-treatment-services-sydney-australia.png'
©2018 neurotreatment.com.au
ACN: 90 129 353 546  Privacy